No. 4 / 2025Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with ...
An anxious sense of wait-and-see may emerge from central banks in the coming week, in their first collective assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results